March 28, 2024

Ron Finklestien

Analysis of The Oncology Institute’s Q4 2023 Financial Performance

TOI stock - TOI Stock Earnings: The Oncology Institute Misses EPS, Beats Revenue for Q4 2023

Source: iQoncept / Shutterstock

The Oncology Institute (NASDAQ:TOI) recently announced its financial results for the fourth quarter of 2023.

  • The company reported an earnings per share of -21 cents, falling short of the analyst consensus of -11 cents.
  • On the revenue front, The Oncology Institute posted $85.79 million, surpassing the analyst forecast of $82.04 million by 4.57%.

InvestorPlace Earnings, powered by data from TradeSmith, delivers automated coverage of quarterly earnings reports. This system provides insights into key metrics such as earnings per share and revenue, while also comparing a company’s performance against analyst expectations.

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/03/toi-stock-earnings-the-oncology-institute-for-q4-of-2023/.

©2024 InvestorPlace Media, LLC

Latest articles



Subscribe to Pivot and Flow Daily